Crossmark

Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity

Published Online: 2018-07-16

Published Print: 2018-12

Authors

Ren, Ruxia

Yin, Shuwen

Lai, Baolong

Ma, Lingzhen

Wen, Jiayong

Zhang, Xuanxuan

Lai, Fangyuan

Liu, Shuwen

Li, Lin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81673481)
License Information

Text and Data Mining valid from 2018-07-16
More Information

Article History

Received: 11 December 2017

Accepted: 10 July 2018

First Online: 16 July 2018

Document is current